Tag Archives: Europe

Europe Turns its Back on Science

Mark Lynas

On October 24th, The New York Times published a great opinion piece titled “With G.M.O. Policies, Europe Turns Against Science. Written by Mark Lynas, political director for the Cornell Alliance for Science at Cornell University and a co-author  of “An Ecomodernist Manifesto,” this piece argues how banning the cultivation of genetically modified crops in certain European countries will a chilling affect on scientific innovation in that part of the world.   “…the chilling effect on biotech science in Europe will be dramatic: Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

EU States Opt-Out of Innovation


A number of international media outlets are reporting on EU member states choosing to opt-out of GMO cultivation.  Using a law signed in March giving countries the right to seek exclusion from any approval request for GMO crop cultivation – even if strains have been approved at EU level – 19 out of 28 EU member states are choosing to ban GMO crops, reports Reuters. Although widely grown in the Americas and Asia, opposition is Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Opening Up Innovation


Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

EU Stem Cell Patent Decision Hurts Science


A great article in the Economist titled European science stemmed addresses the recent and controversial decision by the European Court of Justice regarding the patentability of certain inventions derived from embryonic stem cells. ANY country, you might think, would relish being able to call itself the world’s leader in scientific research. America and Europe, however, seem to be in a bizarre parallel contest: which can make its scientists’ lives more difficult by imposing the most muddled Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,